MaxCyte Stock

MaxCyte Book Value per Share

The Book Value per Share of MaxCyte (MXCT) as of Sep 5, 2026 is 1.93 USD. In the previous year, Book Value per Share was 2.18 USD — a change of -11.16% (lower).

Book Value per Share

1.93USD

YoY

-11.16%

Last updated:

Book Value per Share of MaxCyte is 2026 1.93 USD. Book Value per Share of MaxCyte was 2025 2.18 USD. It decreases by -11.16% lower compared to the previous year.

The MaxCyte Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2017
0.18 USD
Jan 1, 2018
0.12 USD
Jan 1, 2019
0.13 USD
Jan 1, 2020
0.31 USD
Jan 1, 2021
2.46 USD
Jan 1, 2022
2.38 USD
Jan 1, 2023
2.18 USD
Jan 1, 2024
1.93 USD
The MaxCyte Book Value per Share history
YEARBook Value per ShareYoY
1.93USD-11.16%
2.18USD-8.60%
2.38USD-3.39%
2.46USD+691.87%
0.31USD+144.12%
0.13USD+10.57%
0.12USD-37.24%
0.18USD+284.31%
0.05USD-264.52%
-0.03USD+93.75%
-0.01USD—
Access this data via the Eulerpool API
Get Free API Key

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

Book Value per Share of MaxCyte is 1.93 USD in 2026.

Book Value per Share of MaxCyte changed from 2.18 USD to 1.93 USD, representing a -11.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share MaxCyte since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — MaxCyte

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — MaxCyte